Okano JI - Search Results

1

A vein-viewing application enabled detecting abdominal wall varices related to the presence of non-treated gastroesophageal varices: a cross-sectional study.

Hoshino Y, Sugihara T, Ikeda S, Matsuki Y, Nagahara T, Okano JI, Isomoto H. Hoshino Y, et al. Among authors: okano ji. BMC Med Imaging. 2021 Aug 9;21(1):120. doi: 10.1186/s12880-021-00655-8. BMC Med Imaging. 2021. PMID: 34372801 Free PMC article.

2

Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells.

Okano J, Matsumoto K, Nagahara T, Murawaki Y. Okano J, et al. J Gastroenterol. 2006 Feb;41(2):166-76. doi: 10.1007/s00535-005-1736-3. J Gastroenterol. 2006. PMID: 16568376

3

Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.

Matsumoto K, Okano J, Nagahara T, Murawaki Y. Matsumoto K, et al. Int J Oncol. 2006 Dec;29(6):1501-8. Int J Oncol. 2006. PMID: 17088989

4

The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis.

Okano J, Nagahara T, Matsumoto K, Murawaki Y. Okano J, et al. Oncol Rep. 2007 May;17(5):1195-200. Oncol Rep. 2007. PMID: 17390065

5

Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.

Nagahara T, Okano J, Murawaki Y. Nagahara T, et al. Oncol Rep. 2007 Nov;18(5):1281-90. Oncol Rep. 2007. PMID: 17914586

6

Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.

Okano J, Nagahara T, Matsumoto K, Murawaki Y. Okano J, et al. Basic Clin Pharmacol Toxicol. 2008 Jun;102(6):543-51. doi: 10.1111/j.1742-7843.2008.00231.x. Epub 2008 Mar 16. Basic Clin Pharmacol Toxicol. 2008. PMID: 18346049 Free article.

7

The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases.

Matsumoto K, Nagahara T, Okano J, Murawaki Y. Matsumoto K, et al. Oncol Rep. 2008 Oct;20(4):863-72. Oncol Rep. 2008. PMID: 18813828

8

Nucleotide analogs for patients with HBV-related hepatocellular carcinoma increase the survival rate through improved liver function.

Koda M, Nagahara T, Matono T, Sugihara T, Mandai M, Ueki M, Ohyama K, Hosho K, Okano J, Kishimoto Y, Kono M, Maruyama S, Murawaki Y. Koda M, et al. Intern Med. 2009;48(1):11-7. doi: 10.2169/internalmedicine.48.1534. Epub 2009 Jan 1. Intern Med. 2009. PMID: 19122351 Free article.

9

Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats.

Nagahara T, Okano J, Fujise Y, Abe R, Murawaki Y. Nagahara T, et al. Biomed Pharmacother. 2010 May;64(5):319-26. doi: 10.1016/j.biopha.2009.09.023. Epub 2010 Jan 1. Biomed Pharmacother. 2010. PMID: 20434301

10

Preventive effect of caffeine and curcumin on hepato-carcinogenesis in diethylnitrosamine-induced rats.

Fujise Y, Okano J, Nagahara T, Abe R, Imamoto R, Murawaki Y. Fujise Y, et al. Int J Oncol. 2012 Jun;40(6):1779-88. doi: 10.3892/ijo.2012.1343. Epub 2012 Jan 24. Int J Oncol. 2012. PMID: 22293778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters